Research ArticleTechnology/Application

Control Strategy Approach for a Well-Characterized Vaccine Drug Product

Parag Kolhe, Khurram Sunasara, Lavinia Lewis, Michele Bailey Piatchek, Roberto Rodriguez and Katherine Arch-Douglas
PDA Journal of Pharmaceutical Science and Technology March 2020, 74 (2) 213-228; DOI: https://doi.org/10.5731/pdajpst.2018.009415

Article Information

vol. 74 no. 2 213-228
DOI 
https://doi.org/10.5731/pdajpst.2018.009415
PubMed 
31519784
Published By 
Parenteral Drug Association (PDA)
Print ISSN 
1079-7440
Online ISSN 
1948-2124
History 
  • Published online April 9, 2020.

Article Versions

Copyright & Usage 
© PDA, Inc. 2020

Author Information

  1. Parag Kolhe1,*,
  2. Khurram Sunasara1,
  3. Lavinia Lewis1,
  4. Michele Bailey Piatchek1,
  5. Roberto Rodriguez1,† and
  6. Katherine Arch-Douglas1
  1. 1BioTherapeutics Pharmaceutical Sciences, Pfizer Inc, Chesterfield, MO 63017
  1. ↵* Corresponding Author: Pfizer Inc, 1 Burtt Rd., Andover, MA, 01810. Telephone: +1-978-247-1168; e-mail: parag.kolhe{at}pfizer.com

  • ↵† Deceased 2019, formally with Pfizer Inc.

View Full Text

Cited By...

Back to top

In This Issue

Print
Download PDF
Article Alerts
Email Article
Citation Tools
Control Strategy Approach for a Well-Characterized Vaccine Drug Product
Parag Kolhe, Khurram Sunasara, Lavinia Lewis, Michele Bailey Piatchek, Roberto Rodriguez, Katherine Arch-Douglas
PDA Journal of Pharmaceutical Science and Technology Mar 2020, 74 (2) 213-228; DOI: 10.5731/pdajpst.2018.009415
Twitter logo Facebook logo Mendeley logo

Jump to section

Keywords